The 5th International Electronic Conference on Cancers
The 5th International Electronic Conference on Cancers
Part of the International Electronic Conference on Cancers (IECC) series
Event's Timezone: Central European Summer Time
15 March 2026
12 April 2026
7 June 2026
Tumor Microenvironment, Inflammation, Biomarkers, Theranostics, Artificial Intelligence, High-throughput-screening, Molecular Targeting, Cell Plasticity, Personalized Medicine
Abstract Submission Deadline is Closed.
Thank you for submitting your abstract to the IECC 2026.
The abstract acceptance notification will be sent by 12 April 2026.
Registration remains open. Secure your spot and join us for a stimulating conference. Register for free HERE.
For any inquiries, please contact us at iecc2026@mdpi.com.
Welcome from the Chair
Laboratory of Cancer Stem Cell Engineering, Okayama University, Okayama, Japan
More News about MDPI Conferences
Event Chair
Laboratory of Cancer Stem Cell Engineering, Faculty of Interdisciplinary Science and Engineering in Health Systems, Okayama University, Okayama, Japan Website
Masaharu Seno is currently an emeritus professor and the full-professor organizing the Laboratory of Cancer Stem Cell Engineering, Okayama University. Masaharu does research in Biotechnology, Cancer Research and Cell Biology. Their current project is 'Development of CSCs from iPSCs prepared from normal cells and targeting CSCs'.
Session Chairs
Prof. Dr. Angeliki Magklara
1. Laboratory of Clinical Chemistry, Faculty of Medicine, School of Health Sciences, University of Ioannina, Ioannina, Greece; 2. Biomedical Research Institute, Foundation for Research and Technology-Hellas, Ioannina, Greece
Prof. Dr. Sebastiano Mercadante
Main Regional Center for Pain Relief & Palliative Care Unit, La Maddalena Cancer Center, Palermo, Italy
Prof. Dr. Ajay Pratap Singh
Department of Cell and Molecular Biology, University of Mississippi Medical Center, Jackson, USA
Prof. Dr. Henry H. Heng
Center for Molecular Medicine and Genomics, Pathology Department, Wayne State University School of Medicine, Detroit, MI, USA
Dr. Farrukh Aqil
Department of Medicine, University of Louisville, Louisville, USA
Professor. Nicola Amodio
Department of Experimental and Clinical Medicine, University Magna Graecia of Catanzaro, Catanzaro, Italy
Prof. Dr. Ewa Koscielniak
Medical Faculty, University of Tübingen, Tubingen, Germany
Prof. Dr. Andrew A. Gumbs
1. Department of Minimally Invasive Digestive Surgery, Antoine-Béclère Hospital, Greater Paris University Hospitals, Clamart, France; 2. Department of Surgery, Otto von Guericke University Magdeburg, Magdeburg, Germany
Professor Gumbs is the Director of Artificial Intelligence Surgery at the Hôpital Antoine Béclère, Assistance Publique-Hôpitaux de Paris. He is the Editor-in-Chief of Artificial Intelligence Surgery (aisjournal.net) and is the Chief Medical Officer of ACCREA Medical Robotics, which specializes in collaborative interventional robotics. He is also the President and founder of the Artificial Intelligence Organization for the Next generation of Surgeons (AIONS.ai). Professor of Surgery at Grigol Robakidze University and the University of Magdeburg, he was previously Director of the Minimally Invasive Hepatic-Pancreatic-Biliary Surgery Program at SMG-MD Anderson Cancer Center and prior to that the Director of Minimally Invasive Hepatobiliary Surgery and at Fox Chase Cancer Center in Philadelphia, Pennsylvania. He has been Instructor of Clinical Surgery at Cornell-Weill Medical College, Instructor of Clinical Surgery at Columbia University College of Physicians and Surgeons, and Assistant Professor of Surgery in the Department of Surgical Oncology at Fox Chase Cancer Center. He is certified in general surgery, hepatic-pancreatic and biliary surgery, robotic and in laparoscopic surgery. He has delivered local, regional, national, and international invited presentations primarily devoted to minimally invasive surgical techniques for the liver, pancreas, and digestive organs and artificial intelligence surgery. His articles have been published in Annals of Surgery, Surgery, Journal of the American College of Surgeons and the Proceedings of the National Academy of Science. He has volunteered for Doctors Without Borders in the Democratic Republic of the Congo and Haiti and has also done several humanitarian missions to Ecuador.
Prof. Dr. Guo-Min Li
Institute for Cancer Research, Chinese Institutes for Medical Research, Beijing, China
-
Committee Members
Department of Pharmaceutics, College of Pharmacy and Pharmaceutical Sciences, Florida A&M University, Tallahassee, USA
Department of Ophthalmology, University of Padova, Padova, Italy
Second Department of Surgery, Aretaieion Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece
ReGenera R&D International for Aging Intervention and San Babila, Clinic, Vitality Therapeutics, Milano, Italy
Department of Paediatrics and Adolescent Medicine, The University of Hong Kong, Pokfulam, Hong Kong
Department of Biochemistry and Molecular Biology, University of New Mexico, Albuquerque, USA
Department of Radiation Oncology, University of Michigan, Ann Arbor, USA
Department of Radiology Oncology, Centre De Haute Energie, Nice, France
School of Women’s & Children’s Health, University of New South Wales, Sydney, Australia
Department of Pathology and Experimental Cancer Research, Faculty of Medicine, Semmelweis University, Budapest, Hungary
Section of Hematology/Oncology, Children’s Hospital of Pittsburgh of UPMC, Pittsburgh, USA,
The Department of Microbiology and Molecular Genetics, The University of Pittsburgh School of Medicine, Pittsburgh, USA,
The Hillman Cancer Center, The University of Pittsburgh Medical Center, Pittsburgh, USA,
The University of Pittsburgh Liver Research Center, The University of Pittsburgh Medical Center, Pittsburgh, USA
Department of Life Sciences, Link Campus University, Rome, Italy
Department of Public Health Sciences, Sylvester Comprehensive Cancer Center, University of Miami School of Medicine, Miami, USA
Medical Oncology Department, Research Center Cancer Biology & Epigenetics Group and Clinical Trials Department, Institito Portugues de Oncologia do Porto (IPO-Porto), Porto, Portugal
Cancer League of Eastern Switzerland, Flurhofstrasse 7, St. Gallen, Switzerland
University of New Mexico Health Sciences Center, United States
Department of Pathology, New York University Grossman School of Medicine, New York, USA
Department of Immunology and Oncology, National Centre for Biotechnology (CNB-CSIC), Madrid, Spain
Department of Radiology and Imaging, University of Texas Medical Branch at Galveston, Galveston, USA
Nationwide Children’s Hospital Institute for Genomic Medicine and The Ohio State University College of Medicine Depts of Pathology and Pediatrics, Columbus, Ohio USA
Department of Medical Sciences, University of Aveiro, Aveiro, Portugal
Invited Speakers
Department of Hepatobiliary-Pancreatic Surgery, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan
Intraoperative fluorescence imaging for cancer surgery
Professional Activities and Distinctions: Dr. Takeaki Ishizawa received his medical degree in 2000 from The University of Chiba, in Chiba Japan and then went on to complete his Ph.D. in 2008 at The University of Tokyo. In 2011, Dr. Ishizawa stayed in Paris as a fellow at the Institut Mutualiste Montsouris. Dr. Ishizawa performed more than 300 laparoscopic and open hepatobiliary and pancreatic surgeries at the Cancer Institute Hospital, Japanese Foundation for Cancer Research in Tokyo, between 2014 and 2017. Dr. Ishizawa had also participated in liver transplantation at the University of Tokyo Hospital. From April 2022, Dr. Ishizawa supervises hepatobiliary and pancreatic surgery using robot-assisted approach as a Professor of the Department of Hepatobiliary-Pancreatic Surgery at Osaka Metropolitan University. Areas of Research and Publication: Dr. Ishizawa has developed in vivo fluorescence imaging and actively applied these techniques to his clinical practices. So far, Dr. Ishizawa has been published for his work in hepatobiliary and pancreatic surgery and fluorescence-guided surgery in more than 80 peer-reviewed international journals, including the Gastroenterology and the Annals of Surgery. He also played a role as a president of the International Society for Fluorescence Guided Surgery (ISFGS, www.isfgs.org), aiming to share updated information on this topic among researchers, surgeons, and technicians. Dr. Ishizawa has been honored with many prestigious awards including: award from the 106th Annual Congress of Japan Surgical Society, the British Journal of Surgery Award at the 45th Congress of the European Society for Surgical Research, KARL STORZ Award at the 24th Annual Meeting of the Japan Society for Endoscopic Surgery, Best International Abstract Award at SAGES2016, and the 2017 International Guest Scholarship of American College of Surgeons.
Unit of Hematology, AO of Cosenza, Cosenza, Italy
Diagnosis and treatment of Multiple Myeloma
Medical Doctor Day Hospital Department of Hematology – A.O. Annunziata - Cosenza with expertise in Diagnosis and treatment of lymphoproliferative disorders (Hodgkin and non Hodgkin lymphomas, multiple myeloma) Expert on Lymphoproliferative Disorders in Università della Calabria
Sessions
S2. Tumor Heterogeneity
S3. Drug Resistance and Anti-cancer Drug Development and Screening
S4. Cancer Survivorship and Quality of Life
S5. Causes, Diagnosis and Treatment of Cancer
S6. Patterns and Treatment Consideration of Childhood Cancer
S7. Novel Methods and Technologies for Research and Treatment
Registration
The registration for The 5th International Electronic Conference on Cancers will be free of charge! The registration includes attendance to all conference sessions.
If you are registering several people under the same registration, please do not use the same email address for each person, but their individual university email addresses. Thank you for your understanding.
Please note that the submission and registration are two separate parts. Only scholars who registered can receive a link to access the conference live streaming. The deadline for registration is 7 June 2026.
Instructions for Authors
Important Deadlines
1. Deadline for abstract submission: 10 February 2026 15 March 2026.
2. Abstract acceptance notification:10 March 2026 12 April 2026.
Please note:
An abstract acceptance email only confirms that your abstract has been accepted. Oral or poster presentation invitations are determined separately by the conference chairs, and you will receive an additional email with the presentation result.
Abstract Requirements
1. Types of Submissions
- Accepted: Original research abstracts; systematic reviews or meta-analyses abstracts (must comply with PRISMA 2020).
- Not accepted: Narrative, scoping, comparative, perspective, opinion, or essay-style reviews
2. Content Requirements
- Length: 250–300 words
- Structure: Introduction, Methods, Results, Conclusions
- Language: Clear, publication-ready English
- Originality: Must be original and unpublished; previously published abstracts will not be considered
3. Authorship
- The submitting author must ensure all co-authors approve the content.
- Authors may submit multiple abstracts, but only one abstract per author may be selected for an oral presentation.
1. Each abstract must designate one presenter. To change the presenter, please contact us after you receive the oral/poster presentation invitation.
2. Only live presentations are accepted.
3. Presenters who do not attend the live session will not be eligible for awards or presentation certificates.
The slot for the oral presentation is 15 mins. We advise that your presentation lasts for a maximum of 12 mins, leaving at least 3 mins for the Q&A session.
Authors are encouraged to prepare presentations using PowerPoint or equivalent software for online display alongside their abstract. If provided, slides will be presented directly on the conference website via the Sciforum.net slide viewer and should be prepared in the same format as a traditional conference presentation of research results. All slides must be converted to PDF format prior to submission to ensure accurate online display.
Each presentation should:
- Communicate the research question or objective, methodology, key results, and scientific novelty;
- Use a clear and logical structure, typically Introduction-Methods-Results&Discussion structure (IMRaD) or a field-appropriate alternative;
- Emphasize the relevance of the work;
- Support key findings with clear figures or tables where appropriate;
- Conclude with a critical interpretation of the results and their impact.
Posters should be designed to allow independent understanding of the research and clearly present the essential elements of the study.
Each poster should include:
- Title, authors, affiliations, and contact details (clearly displayed at the top);
- Brief introduction outlining the research objective;
- Concise methodology summary;
- Main results, supported by clear, well-labeled figures or tables where appropriate;
- Short conclusion summarizing key findings and their relevance.
Technical specifications:
Dimensions (cm): 84.1 × 118.9 (A0 - portrait)
Resolution: 300 dpi
Pixel size (portrait, 300 dpi): 9933 × 14043 px
Minimum font size: ≥24
The poster template can be downloaded HERE. We will reach out to you closer to the dates of the conference with more information.
Note: The uploaded poster may be used as provided and serves as a reference. However, as long as the technical specifications are followed, scholars are welcome to use any poster template of their choice.
It is the author's responsibility to identify and declare any personal circumstances or interests that may be perceived as inappropriately influencing the representation or interpretation of clinical research. If there is no conflict, please state "The authors declare no conflicts of interest." This should be conveyed in a separate "Conflict of Interest" statement preceding the "Acknowledgments" and "References" sections at the end of the manuscript. Any financial support for the study must be fully disclosed in the "Acknowledgments" section.
MDPI, the publisher of the Sciforum.net platform, is an open access publisher. We believe authors should retain the copyright to their scholarly works. Hence, by submitting an abstract to this conference, you retain the copyright to the work, but you grant MDPI the non-exclusive right to publish this abstract online on the Sciforum.net platform. This means you can easily submit your full paper (with the abstract) to any scientific journal at a later stage and transfer the copyright to its publisher if required.
Publication Opportunities
Participants in this conference are cordially invited to contribute a full manuscript to the conference's Special Issue published in Cancers (ISSN: 2072-6694 , Impact Factor 4.4), with a 20% discount on the publication fee. Please note if you have IOAP/association discounts, conference discounts will be combined with IOAP/association discounts. Conference discounts cannot be combined with reviewer vouchers. All submitted papers will undergo MDPI’s standard peer-review procedure. The abstracts should be cited and noted on the first page of the paper.
Special Issue Submission Deadline: 30 June 2027
Accepted abstracts will be included in the conference report of the 5th International Electronic Conference on Cancers, published in the Medical Sciences Forum (ISSN: 2673-9992). Authors of accepted abstracts are highly encouraged to submit an extended proceeding paper (ideally 4-8 pages in length) for free, please submit it to the same journal after the conference.
Proceedings paper submission deadline: 27 July 2026.
Please click HERE to submit your proceedings paper to Medical Sciences Forum, and be sure to disclose the conference information in your cover letter or mention the conference name in your submission.
IECC 2026_proceeding_paper-template.dot
Publication Notice: Proceedings papers will undergo peer-review procedure. Acceptance at the conference does not ensure final publication.
Manuscripts for the proceedings issue must be formatted as follows:
Title;
Full author names;
Affiliations (including full postal address) and authors' e-mail addresses;
Abstract;
Keywords;
Introduction;
Methods;
Results and Discussion;
Conclusions;
Acknowledgements;
References.
Event Awards
The Awards
Number of Awards Available: 6
Eligibility: Open to all authors selected as oral speakers who have delivered their presentation. Failure to present, delegation of the presentation to another person, or use of AI-generated voice or similar substitutes will result in disqualification.
Criteria: Evaluation considers scientific rigor (clear, literature-supported research question or hypothesis, appropriate methodology, robust analysis and critical discussion of the results), IMRaD/field-appropriate structure, clarity of presented data (clear, well-labeled figures and tables), presentation skills and audience engagement, demonstrated scientific novelty and impact.
Prize: An award of CHF 200 and a certificate in recognition of your outstanding contribution.
Best Poster Award
Eligibility: Open to all authors who have presented their work through posters. Failure to present, delegation of the presentation to another person, or use of AI-generated voice or similar substitutes will result in disqualification.
Criteria: Evaluation considers scientific rigor (clear, literature-supported research question or hypothesis, appropriate methodology, robust analysis, and critical discussion of the results), IMRaD/field-appropriate structure enabling independent understanding, clarity of presented data (clear, well-labeled figures and tables), presentation skills (if orally presented), demonstrated scientific novelty and impact.
Prize: An award of CHF 200 and a certificate in recognition of your outstanding contribution.
Winner Announcement: The award winners will be evaluated and selected by the scientific committee after the conference. Results will be announced on the website and all winners will be individually contacted via email.
Sponsors and Partners
For information regarding sponsorship and exhibition opportunities, please click here.
Organizers
Media Partners
Conference Secretariat
Ms. Ann Li
Mr. Russell Wang
Ms. Chloe Lv
Email: iecc2026@mdpi.com
For inquiries regarding submissions and sponsorship opportunities, please feel free to contact us.
